1. Inicio
  2. Publicaciones
  3. Systematic review and meta-analysis: the incidence and prevalence of paediatric coeliac disease across Europe

Systematic review and meta-analysis: the incidence and prevalence of paediatric coeliac disease across Europe

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Roberts, SE
  • Morrison-Rees, S
  • Thapar, N
  • Benninga, MA
  • Borrelli, O
  • Broekaert, I
  • Dolinsek, J
  • Martin-de-Carpi, J
  • Mas, E
  • Miele, E
  • Pienar, C
  • Thomassen, RA
  • Thomson, M
  • Tzivinikos, C
  • Thorne, K
  • John, A
  • Williams, JG

Grupos

Abstract

Background Coeliac disease is one of the most prevalent immune-mediated gastrointestinal disorders in children. Aim To review the incidence and prevalence of paediatric coeliac disease, and their trends, regionally across Europe, overall and according to age at diagnosis. Methods Systematic review and meta-analysis from January 1, 1950 to December 31, 2019, based on PubMed, CINAHL and the Cochrane Library, searches of grey literature and websites and hand searching of reference lists. A total of 127 eligible studies were included. Results The prevalence of previously undiagnosed coeliac disease from screening surveys (histology based) ranged from 0.10% to 3.03% (median = 0.70%), with a significantly increasing annual trend (P = 0.029). Prevalence since 2000 was significantly higher in northern Europe (1.60%) than in eastern (0.98%), southern (0.69%) and western (0.60%) Europe. Large increases in the incidence of diagnosed coeliac disease across Europe have reached 50 per 100 000 person-years in Scandinavia, Finland and Spain. The median age at diagnosis increased from 1.9 years before 1990 to 7.6 since 2000. Larger increases in incidence were found in older age groups than in infants and ages Paediatric coeliac disease incidence and prevalence have risen across Europe and appear highest in Scandinavia, Finland and Spain. The most recent evidence shows large increases in incidence in most regions, but stabilisation in some (notably Sweden and Finland). Sharp increases in the age at diagnosis may reflect increases in milder and asymptomatic cases diagnosed since reliable serology testing became widely used, through endomysial antibodies after 1990 and tissue transglutaminase antibodies around 2000.

Datos de la publicación

ISSN/ISSNe:
0269-2813, 1365-2036

ALIMENTARY PHARMACOLOGY & THERAPEUTICS  BLACKWELL PUBLISHING

Tipo:
Review
Páginas:
109-128
PubMed:
34115894
Factor de Impacto:
2,850 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 53

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • LOW INCIDENCE RATES; ANTIBODY-TEST; TISSUE TRANSGLUTAMINASE; CLINICAL PRESENTATION; DERMATITIS-HERPETIFORMIS; ANTIGLIADIN ANTIBODIES; CUMULATIVE INCIDENCE; DIAGNOSTIC-ACCURACY; DANISH POPULATION; RISING INCIDENCE

Campos de Estudio

Cita

Compartir